Skip to main content
. 2021 Nov 3;9(11):1269. doi: 10.3390/vaccines9111269

Table 6.

Difference in reporting of systemic adverse reactions in the 7 days after the first and second vaccine dose administration.

Dose 1 Dose 2 Sig.
Fever 5.5% (95%CI 2.8–9.6) 32.0% (95%CI 25.6–38.9) 0.000
Fatigue 41.5% (95%CI 34.6–48.7) 74.5% (95%CI 67.9–80.4) 0.000
Chills 12.0% (95%CI 7.8–17.3) 40.0% (95%CI 33.2–47.1) 0.000
Headache 34.5% (95%CI 27.9–41.5) 55.5% (95%CI 48.3–62.5) 0.000
Muscle/joint pain 25.5% (95%CI 19.6–32.1) 56.0% (95%CI 48.8–63.0) 0.000
Gastrointestinal symptoms 6.0% (95%CI 3.1–10.2) 15.0% (95%CI 10.4–20.7) 0.003
Lymph node enlargement 10.5% (95%CI 6.6–15.6) 18.5% (95%CI 13.4–24.6) 0.015